Endovascular Treatment of Cerebral Aneurysms Using the Hydrocoil Embolic System. Issue 4 (August 2013)

• Record Type: Journal Article
• Authors: Briganti, F.; Leone, G.; Panagiotopoulos, K.; Marseglia, M.; Mariniello, G.; Napoli, M.; Caranci, F.
• Is Part Of: Neuroradiology journal. Volume 26:Issue 4(2013)
• Page Start: 420
• Page End: 427
• Publication Date: 2013-08
• Subjects: cerebral aneurysms -- embolization -- hydrocoil embolic system -- Guglielmi detachable coils; Nervous system -- Radiography -- Periodicals; Neuroradiography -- Periodicals; Electronic journals; 616.804757
• DOI: 10.1177/197140091302600407
• Languages: English
• ISSNs: 1971-4009

Abstract

HydroCoils are platinum helical coils coated with a layer of hydrophilic acrylic polymer (hydrogel), which on contact with blood causes disentanglement of polymer chains and expansion. We retrospectively reviewed a series of 29 patients harboring 29 cerebral aneurysms treated with the Hydrocoil Embolic System in the period 2004–2005, discussing the results of endovascular procedures in terms of safety and efficacy. The immediate post-procedure angiographic control demonstrated complete aneurysm occlusion in 21 cases (72.4%), near-complete occlusion in seven cases (24.1%), whereas in one case (3.4%) there was a procedure failure with major perfusion of the sac. Five patients (17.2%) experienced thromboembolic complications, including an asymptomatic lacunar stroke of the head of the caudate nucleus, a thalamic infarct following hypotension secondary to pulmonary edema, temporal ischemia secondary to vasospasm and a small right occipital ischemic lesion. Only one patient (3.4%) suffered a major ischemic accident. No other procedure-related complication occurred. Three-month follow-up control with MR angiography and 12-month follow-up angiography demonstrated no recurrence of aneurysms. Overall, after a mean follow-up of 12 months, the clinical outcome was good recovery in 26 patients (89.6%), moderate disability in three patients (10.3%) and no vegetative status or death. Our HydroCoil series supports the safety and midterm durability of hydrogel-coated aneurysm coils in the treatment of cerebral aneurysms.